Paclitaxel

Novocure TTFields
MedTech

Novocure gets FDA nod for device targeting pancreatic cancer

The FDA gave the go-ahead to Novocure for its tumor-treating electric fields device that targets advanced pancreatic cancer alongside a drug combo.
Joseph Keenan Feb 17, 2026 4:15am
visual of red blood cells

Bos Sci nets first US approval for drug-coated coronary balloon

Mar 1, 2024 1:49pm
Novocure TTFields

Novocure's electric fields fail phase 3 ovarian cancer trial

Aug 28, 2023 10:15am
FDA

FDA greenlights Urotronic's drug-coated balloon for BPH

Jul 17, 2023 10:28am
Red blood cells

FDA rolls back warnings for paclitaxel-coated balloons, stents

Jul 13, 2023 1:15pm
red blood cells

ACC: Study finds no increased death risk with paclitaxel devices

May 16, 2021 5:30pm